Next Article in Journal
Triple-Negative Breast Cancer and Emerging Therapeutic Strategies: ATR and CHK1/2 as Promising Targets
Previous Article in Journal
A Phase I Study of the Oral Dual-Acting Pan-PI3K/mTOR Inhibitor Bimiralisib in Patients with Advanced Solid Tumors
 
 
Systematic Review

Article Versions Notes

Cancers 2024, 16(6), 1140; https://doi.org/10.3390/cancers16061140
Action Date Notes Link
article xml file uploaded 13 March 2024 12:05 CET Original file -
article xml uploaded. 13 March 2024 12:05 CET Update https://www.mdpi.com/2072-6694/16/6/1140/xml
article pdf uploaded. 13 March 2024 12:05 CET Version of Record https://www.mdpi.com/2072-6694/16/6/1140/pdf
article supplementary file uploaded. 13 March 2024 12:05 CET - https://www.mdpi.com/2072-6694/16/6/1140#supplementary
article html file updated 13 March 2024 12:06 CET Original file https://www.mdpi.com/2072-6694/16/6/1140/html
Back to TopTop